Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Boehringer Ingelheim
Medtronic
McKesson
Mallinckrodt

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

HUMALOG Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Humalog patents expire, and when can generic versions of Humalog launch?

Humalog is a drug marketed by Lilly and Eli Lilly And Co and is included in four NDAs. There is one patent protecting this drug.

The generic ingredient in HUMALOG is insulin lispro protamine recombinant; insulin lispro recombinant. There are forty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.

Drug patent expirations by year for HUMALOG
Drug Prices for HUMALOG

See drug prices for HUMALOG

Drug Sales Revenue Trends for HUMALOG

See drug sales revenues for HUMALOG

Recent Clinical Trials for HUMALOG

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eli Lilly and CompanyPhase 2
Sandra SobelPhase 4
Massachusetts General HospitalPhase 2/Phase 3

See all HUMALOG clinical trials

Pharmacology for HUMALOG
Ingredient-typeInsulin
Drug ClassInsulin Analog

US Patents and Regulatory Information for HUMALOG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563-001 Jun 14, 1996 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lilly HUMALOG MIX 75/25 insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021017-001 Dec 22, 1999 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lilly HUMALOG MIX 50/50 insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021018-001 Dec 22, 1999 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lilly HUMALOG MIX 75/25 KWIKPEN insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021017-002 Sep 6, 2007 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Lilly HUMALOG KWIKPEN insulin lispro recombinant INJECTABLE;INJECTION 020563-003 Sep 6, 2007 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Eli Lilly And Co HUMALOG KWIKPEN insulin lispro recombinant SOLUTION;SUBCUTANEOUS 205747-001 May 26, 2015 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Moodys
Johnson and Johnson
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.